(20 days)
The intended use of the Mobile Compact Digital Cardiac (MCDCC) is to detect the location and distribution of gamma ray emitting radionuclides in the body and store data for analysis. This device resides on a mobile platform and includes accessories such as signal analysis and display equipment, patient and equipment supports, radionuclide anatomical markers, component parts and accessories.
The Mobile Compact Digital Cardiac Camera (MCDCC) is a gamma camera system. It includes a detector head, gantry, and resides on a mobile platform. It includes accessories such as signal analysis and display equipment supports, radionuclide anatomical markers, component parts and accessories.
This document is a 510(k) summary for the Mobile Compact Digital Cardiac Camera (MCDCC). It does not contain acceptance criteria or the results of a study that proves the device meets specific performance criteria.
Instead, this submission focuses on demonstrating substantial equivalence to a predicate device (Compact Digital Cardiac Camera, K033199). This means the manufacturer is asserting that the new device is as safe and effective as a legally marketed device and does not introduce new questions of safety or effectiveness.
Therefore, I cannot provide the requested information regarding acceptance criteria and performance study details from the given text.
Here's why each point cannot be answered:
- A table of acceptance criteria and the reported device performance: This information is not present. The document focuses on comparing design features and intended use to a predicate device.
- Sample sized used for the test set and the data provenance: No performance testing data is presented, and thus no sample sizes or data provenance are mentioned.
- Number of experts used to establish the ground truth for the test set and the qualifications of those experts: This is irrelevant to a substantial equivalence claim, as no new performance study is being presented.
- Adjudication method (e.g. 2+1, 3+1, none) for the test set: Not applicable as no test set or expert adjudication is described for performance evaluation.
- If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: Not applicable. This device is a gamma camera, not an AI-assisted diagnostic tool for human readers.
- If a standalone (i.e. algorithm only without human-in-the-loop performance) was done: Not applicable. The device is a medical imaging system, not an algorithm being tested in isolation.
- The type of ground truth used (expert concensus, pathology, outcomes data, etc): Not applicable as no new performance study with ground truth establishment is detailed.
- The sample size for the training set: Not applicable as this is not an AI/ML device that undergoes training.
- How the ground truth for the training set was established: Not applicable for the same reason as above.
The core of this 510(k) is the statement: "The Mobile Compact Digital Cardiac Camera (MCDCC) has been deemed safe and is certified to the same safety standards as the predicate device by a third party organization prior to use on patients. A matrix was constructed comparing the features and intended use of the Mobile Compact Digital Cardiac Canera (MCDCC) with the predicate device. We conclude that the Mobile Compact Digital Cardiac Camera (MCDCC) is substantially equivalent to the predicate device and that no new safety or effectiveness concerns are raised." This indicates a comparison study of design and function, not a clinical performance study with specific acceptance criteria.
{0}------------------------------------------------
FEB - 2 2004
Image /page/0/Picture/1 description: The image shows handwritten text that appears to be a document identifier or page number. The text includes the string 'K040051' at the top, followed by 'Page 1 of 2' on the next line. There is also a number '1' at the bottom of the image.
501(k) SUMMARY
SUBMITTERS IDENTIFICATION
| Applicant's Name and Street Address: | IS2 Medical Systems Inc.20 Gurdwara Rd., Units 3-10Ottawa, Ontario, CanadaK2E 8B3 |
|---|---|
| Manufacturing Site: | IS2 Medical Systems Inc.20 Gurdwara Rd., Units 3-10Ottawa, Ontario, CanadaK2E 8B3 |
| FDA Registration # | 9615403 |
| Contact Person: | Victor Woodburn, Manager Quality and Regulatory |
| Contact Person E-mail address: | vwoodburn@is2medical.com |
| Telephone and Fax Number of Contact Person: | T- (613) 228-8755, F-(613) 228-8228 |
| Date of Submission: | January 6, 2004 |
| DEVICE NAME | |
| Device Name (Common): | Gamma Camera |
| Proprietary Name: | Mobile Compact Digital Cardiac Camera |
| Classification Name: | Emission Computed Tomography System |
| Product Code: | 90-KPS |
| CFR: | 21CFR 892.1200 |
| Device Class: | II |
| Predicate Device: | Compact Digital Cardiac Camera |
| (Predicate) 510(k) No.: | K033199 |
| Labelling: | Labels and Instructions for Use can be found in Attachment 1.No changes to the labels or Instructions for Use have occurred. |
{1}------------------------------------------------
Kou 005
Page 2 of 2
INTRODUCTION
This 510(k) Premarket Notification has been prepared to demonstrate that the Mobile Compact Digital Cardiac Camera (MCDCC), manufactured by IS2 Medical Systems Inc., is substantially equivalent to the Compact Digital Cardiac Camera (CDCC), which has previously been through the 510(k) premarket notification process on 510(k) K032779. The mobile system include the mounting of the mobile platform incorporating the use of "Dome Mounting " pads to facilitate high load isolation.
INTENDED USE
The intended use of the Mobile Compact Digital Cardiac Camera (MCDCC) is to detect the location and distribution of gamma ray emitting radionuclides in the body and store data for analysis. This device includes accessories such as signal analysis and display equipment supports, radionuctide anatomical markers, component parts and accessories. The Indications for Use statement can be found in Attachment 2.
DETERMINATION OF SUBSTANTIAL EQUIVALENCE
The intended use of the Mobile Compact Digital Cardiac Camera (MCDCC) is the same range of studies to that of the Compact Digital Cardiac Canera (CDCC) K033199. The detector head is identical in hardware and software. The gantry of the Mobile Compact Digital Cardiac Canera (MCDCC) is optinised for being attached to a mobile platform which is transported from location to location in a truck and has the same range of automatic clinical motions of Compact Digital Cardiac Camera (CDCC) K033199.
The Mobile Compact Digital Cardiac Camera (MCDCC) has been deemed safe and is certified to the same safety standards as the predicate device by a third party organization prior to use on patients. A matrix was constructed comparing the features and intended use of the Mobile Compact Digital Cardiac Canera (MCDCC) with the predicate device. We conclude that the Mobile Compact Digital Cardiac Camera (MCDCC) is substantially equivalent to the predicate device and that no new safety or effectiveness concerns are raised.
{2}------------------------------------------------
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized image of an eagle with its wings spread, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged in a circular pattern around the eagle. The eagle is composed of several lines, giving it a modern and abstract appearance.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
FEB - 2 2004
Mr. Victor Woodburn Manager Quality and Regulatory Affairs IS2 Medical Systems, Inc. Medical Diagnostic Imaging 20 Gurdwara Road, #3-10 Ottawa, Ontario, K2E 8B3 CANADA
Re: K040057 Trade/Device Name: Mobil Compact Digital Cardiac Camera (MCDCC) Regulation Number: 21 CFR 892.1200 Regulation Name: Emission computed tomography system Regulatory Class: II Product Code: 90 KPS Dated: January 12, 2004 Received: January 14, 2004
Dear Mr. Woodburn:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050
{3}------------------------------------------------
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of the letter:
| 8xx.1xxx | (301) 594-4591 |
|---|---|
| 876.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4616 |
| 884.2xxx, 3xxx, 4xxx, 5xxx, 6xxx | (301) 594-4616 |
| 892.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4654 |
| Other | (301) 594-4692 |
Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding, by reference to premarket notification" (21CFR Part 807.97) you may obtain. Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.
Sincerely yours,
Nancy C. Brogdon
Nancy C. Brogdon Director, Division of Reproductive, Abdominal and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
Page _ of _
510(k) Number (K040057)
Device Name: Mobile Compact Digital Cardiac (MCDCC)
Concra
Indications for Use: The intended use of ray emitting radionuclides in the body and store data for analysis. This device resides on a mobile platform and includes accessories such as signal analysis and display equipment, patient the Mobile Compact Digital Cardiac (MCDCC) is to detect the location and distribution of gamma and equipment supports, radionuclide anatomical markers, component parts and accessories.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use
OR
(Pcr 21 CFR 801.109)
(Division Sign-Off)
Over-The-Counter Use No
(Optional Formal ! 2-90
Division of Reproductive, Abdominal,
and Radiological Devices
510(k) Number KC40057
RECEIVED DATE · 01/16 15-17'04 FROM : 3014804224
§ 892.1200 Emission computed tomography system.
(a)
Identification. An emission computed tomography system is a device intended to detect the location and distribution of gamma ray- and positron-emitting radionuclides in the body and produce cross-sectional images through computer reconstruction of the data. This generic type of device may include signal analysis and display equipment, patient and equipment supports, radionuclide anatomical markers, component parts, and accessories.(b)
Classification. Class II.